Journal of the American Chemical Society
change at C5' (Figure S19). Likewise, when the reaction tural variation and the biological activity important for the
Page 4 of 6
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
18
18
18
was conducted in H
2
O (90% O), no O-labeling was
survival of the producing microorganisms.
found in 29 as would be expected for β-epimerization
involving hydroxyl-exchange at C5' (Figure S19). These
observations rule out b-epimerization (i.e., at C5') as the
process leading to 29 and thus indicate that AbmD-
catalyzed epimerization only occurs at the a-carbon (i.e.,
C6') of the amino acid moiety (Figure S20). Hence, the
AbmD-substrate, which is the AbmH-product, is (5'S,6'S)-
28.
ASSOCIATED CONTENT
The Supporting Information is available free of charge on
the ACS Publications website (http://pubs.acs.org)
Details regarding experimental procedures and spectro-
scopic data (PDF).
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
AUTHOR INFORMATION
The demonstrated activities of AbmH and AbmD strong-
ly suggest that 8ribo is the substrate in the AbmH-catalyzed
C5'–C6' formation. However there remains the possibility
that the natural substrates of AbmH and AbmD are actually
Corresponding Author
*h.w.liu@mail.utexas.edu
ORCID
Hung-wen Liu: 0000-0001-8953-4794
4
'-oxynucleosides rather than 4'-thionucleosides such that
the sulfur atom is inserted after the AbmH/AbmD-
catalyzed reactions. To investigate this possibility, com-
pound 30 (existing as its hydrate form 31) was chemically
synthesized and incubated with AbmH under the standard
assay conditions (Figure 2E). Two products were formed in
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENT
This work was supported by grants from the National Insti-
tutes of Health (GM035906 and 1 S10 OD021508-01 for
NMR) and the Welch Foundation (F-1511). We thank Jessi
Cai for her assistance in the preparation of AbmH.
~
1:1 ratio (Figure S21). One was identified as 32 with a
threo-configuration (5'S,6'S) at C5'/C6' (J5',6' = 5.2 Hz in the
carbamate form) and the other was an erythro-heptose nu-
cleoside (5'R,6'S)-33 (J5',6' = 9.7 Hz in the carbamate form)
based on the results of phosgene derivatization and com-
parison with standards (Supporting Information and Figure
S22). These observations showed that the 4'-oxynucleoside
can also be converted by AbmH, but with much reduced
diastereoselectivity and catalytic efficiency (a 14-fold dif-
REFERENCES
(1)(a) Gause, G. F. Recent studies on albomycin, a new antibiotic. Brit.
Med. J. 1955, 12, 1177−1179. (b) Stapley, E. O.; Ormond, R. E. Similarity
of albomycin and grisein. Science 1957, 125, 587−589. (c) Lin, Z.; Xu, X.;
Zhao, S.; Yang, X.; Guo, J.; Zhang, Q.; Jing, C.; Chen, S.; He, Y. Total syn-
thesis and antimicrobial evaluation of natural albomycins against clinical
pathogens. Nat. Commun. 2018, 9, 3445.
ference between kcat/K for 26/27 vs. 30/31, see TableS1).
m
Moreover, when the AbmH-products 32 and 33 were sepa-
rately incubated with AbmD, no epimerization was ob-
served in either case (Figure S23). These results indicate
that AbmD can recognize the 4'-thiosugar 28 but not 4'-
oxysugars 32/33. Accordingly, the sulfur atom must be
incorporated into the sugar skeleton early in the biosynthe-
(2)(a) Benz, G. Enzymatische spaltung der desferriform der albomycine d
1
,
d
2
. Liebigs Ann Chem, 1984, 1399−1407. (b) Benz, G.; Born, L.; Brieden,
M.; Grosser, R.; Hurz, J.; Paulsen, H.; Sinnwell, V.; Weber, B. Absolute
konfiguration der desferriform der albomycine. Liebigs Ann Chem, 1984,
1
408−1423. (c) Paulsen, H.; Brieden, M.; Benz, G. Synthese des sauersstof-
fanalogons der desferriform von d -Albomycin. Liebigs Ann Chem, 1987,
65−575.
1
sis of 1. However, the apparent kcat/K of AbmD with 29
m
5
-4
-1
-1
was estimated to be only (5.2 ± 0.3) × 10 min •µM (Fig-
(3)(a) Pramanik, A.; Braun, V. Albomycin uptake via a Ferric hydroxamate
transport system of Streptococcus pneumoniae R6. J. Bacteriol. 2006, 188,
3878−3886. (b) Ferguson, A. D.; Braun, V.; Fiedler, H. P.; Coulton, J. W.;
Diederichs, K.; Welte, W. Crystal structure of the antibiotic albomycin in
complex with the outer membrane transporter FhuA. Protein Sci. 2008, 9,
ure S25). While the poor catalytic efficiency of AbmD with
2
9 may be a consequence of 29 bearing a uracil rather than
the biosynthetically more relevant cytosine nucleobase, the
physiological substrate for the AbmD reaction ultimately
remains ambiguous. Therefore, additional experiments will
be needed to resolve this question and establish the timing
between the AbmH and AbmD reactions.
9
56−963. (c) Clarke, T. E.; Braun, V.; Winkelmann, G.; Tari, L. W.; Vogel,
H. J. X-ray crystallographic structures of the Escherichia coli periplasmic
protein FhuD bound to hydroxamate-type siderophores and the antibiotic
albomycin. J. Biol. Chem. 2002, 277, 13966–13972.
(
4) Stefanska, A. L.; Fulston, M.; Houge-Frydrych, C. S. V.; Jones, J. J.;
In summary, the in vitro investigation of the substrate
specificity and stereochemistry of the AbmH/AbmD-
catalyzed reactions in conjunction with the abmJ deletion
study establish several key steps in the assembly of the
thioheptose core during biosynthesis of albomycins. Alt-
hough epimerizations catalyzed by AbmD and AbmJ do
not result in major structural alterations, they appear to be
essential for conferring the antimicrobial activity of 1. The
present study not only reveals the intricacy of the construc-
tion of a thionucleoside-containing natural product, but also
enhances our knowledge regarding the correlation of struc-
Warr, S. R. A potent seryl tRNA synthetase inhibitor SB-217452 isolated
from a Streptomyces species. J. Antibiot. 2000, 53, 1346−1353.
(5) Zeng, Y.; Kulkarni, A.; Yang, Z.; Patil, P. B.; Zhou, W.; Chi, X.; Van
Lanen, S.; Chen, S. Biosynthesis of albomycin d provides a template for
assembling siderophore and aminoacyl-tRNA synthetase inhibitor conju-
2
gates. ACS Chem. Biol. 2012, 7, 1565−1575.
(
6) (a) Winn, M.; Goss, R.J.; Kimura, K.; Bugg, T. D. Antimicrobial nucle-
oside antibiotics targeting cell wall assembly: recent advances in structure-
function studies and nucleoside biosynthesis. Nat. Prod. Rep. 2010, 27,
2
79–304. (b) Walsh, C. T.; Zhang, W. Chemical logic and enzymatic ma-
chinery for biological assembly of peptidyl nucleoside antibiotics. ACS
Chem. Biol. 2011, 6, 1000−1007.
4
ACS Paragon Plus Environment